Why There is No Need to Concentrate A2M
Concentration of A2M has become a hot topic in treating arthritis with autologous biologics. Dr. Centeno discusses why at this point with what we know, why this makes little common or scientific sense.
Free Regenexx® Webinar
Join Chris Centeno, M.D., founder of Regenexx, to learn about how Regenexx procedures can treat your orthopedic injury.
View WebinarFind a Regenexx Provider
Regenexx is a world-wide network of specially trained physicians providing the world's most advanced, research-driven, regenerative interventional orthopedic procedures in North America, Europe, the Middle East, Asia and Australia.